Journal profile · PERIPHERAL VASCULAR DISEASE
International Journal Cardiology Hypertension
ISSN 2590-0862 · eISSN 2772-4875 · Elsevier · Netherlands
International Journal Cardiology Hypertension: impact factor 3 (journal website); fully open access; APC about USD 2,760; median 73 days to acceptance (99 articles, last 24 months); 14 articles a year.
Scope
Aims, scope and focus
International Journal Cardiology Hypertension is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Blood Pressure and Hypertension Studies, Sodium Intake and Health and Cardiovascular Health and Disease Prevention, together about 43.3% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
The source of cutting-edge insights into cardiovascular risk factors and preventionInternational Journal of Cardiology: Cardiovascular Risk and Prevention (IJCCRP) is the successor to International Journal of Cardiology: Hypertension with a broader scope.It is the official journal of the ITalian Alliance of CArdiovascular REhabilitation and Prevention (ITACARE-P). Companion journal to International Journal of Cardiology, IJC Heart & Vasculature and International Journal of Cardiology Congenital Heart DiseaseThe International Journal of Cardiology: Cardiovascular Risk and Prevention is an online-only, open-access journal dedicated to publishing peer-reviewed original papers and reviews in the field of cardiovascular risk factors (hypertension, lipids, smoking, obesity, diabetes, and novel risk factors), cardiovascular epidemiology, genetics, and prevention, to include basic, translational, and clinical research.
From the journal's Aims & Scope
Research area (LetPub): PERIPHERAL VASCULAR DISEASE
Editor-in-chief Daniel LevyPublisher website
Editorial board by country: 2 in mainland China (about 2%); most named Italy 21, United States 20, Germany 5, France 3, Denmark 3 (82 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Blood Pressure and Hypertension StudiesMedicine25.7%
- Sodium Intake and HealthNursing10.8%
- Cardiovascular Health and Disease PreventionMedicine6.8%
- Heart Rate Variability and Autonomic ControlMedicine6.1%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine5.4%
- Cardiovascular Function and Risk FactorsMedicine4.1%
- Hormonal Regulation and HypertensionMedicine4.1%
- Health Promotion and Cardiovascular PreventionMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 3Publisher website ·
- CiteScore (publisher)
- 3.1Publisher website ·
- h-index
- 17OpenAlex ·
- i10-index
- 35OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 14LetPub ·
Articles by year OpenAlex count · 82 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2021 | 16 | 16 | 89 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
73 daysMedian, submission to acceptance · P25–P75 25 days – 113 days
- Acceptance to online
- median 2 days (99 articles)
- Submission to online
- median 76 days
- Sample
- 99 articles with submission and acceptance dates (380 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 13 weeksLetPub ·
- Submission to first decision
- 8 daysPublisher website ·
- First decision after review
- 52 daysPublisher website ·
- Submission to acceptance
- 77 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Submission to publication (journal-reported)
- about 15 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,760 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 2,800 / EUR 2,490 / GBP 2,200 / JPY 300,910 | — | — | |
| LetPub | USD 2,800 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Manuscript length
- ≤ 3,500 words
- Reference style
- Numbered, in order of citation
- Highlights
- Optional
- Graphical abstract
- Required
Article types accepted7, with length limits
- case reportThe International Journal of Cardiology Cardiovascular Risk and Prevention is a global journal with a focus on hypertension that welcomes the following types of…main text ≤ 2,000 words
- case reportsCase Reports:Text in these articles should not exceed 2000 words (word limit excludes the title page with list of authors and their affiliations, abstract, refe…Length not stated
- controversies in hypertensionControversies in Hypertension:Text in these articles should not exceed 2500 words (word limit excludes the title page with list of authors and their affiliation…Length not stated
- correspondenceThe International Journal of Cardiology Cardiovascular Risk and Prevention is a global journal with a focus on hypertension that welcomes the following types of…Length not stated
- hypertension highlightsHypertension Highlights:Text in these articles should not exceed 1500 words (word limit excludes the title page with list of authors and their affiliations, abs…Length not stated
- research paperThe International Journal of Cardiology Cardiovascular Risk and Prevention is a global journal with a focus on hypertension that welcomes the following types of…main text ≤ 3,500 words
- review articleThe International Journal of Cardiology Cardiovascular Risk and Prevention is a global journal with a focus on hypertension that welcomes the following types of…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- Netherlands
- Language
- English
- ISSN
- 2590-0862
- Electronic ISSN
- 2772-4875
- Society / sponsor
- ITalian Alliance of CArdiovascular REhabilitation and Prevention
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about International Journal Cardiology Hypertension
What is the impact factor of International Journal Cardiology Hypertension?
The journal's website gives an impact factor of 3; this is the journal's own figure, as LetPub lists none for it; h-index 17.
How long does peer review take at International Journal Cardiology Hypertension?
Based on the dates recorded on 99 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 73 days (interquartile range 25–113 days); authors report an average review time of about 13 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of International Journal Cardiology Hypertension?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Manuscript length: ≤ 3,500 words; Reference style: Numbered, in order of citation; Highlights: Optional; Graphical abstract: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of International Journal Cardiology Hypertension based?
Of the 82 board members whose country the journal's board page names, 2 (about 2%) are in mainland China; the countries named most often are Italy (21), United States (20) and Germany (5). Counted from the institutions listed on the board page; for reference only.
Which databases index International Journal Cardiology Hypertension?
According to LetPub and DOAJ records, International Journal Cardiology Hypertension is indexed in DOAJ.
Is International Journal Cardiology Hypertension open access, and what is the APC?
International Journal Cardiology Hypertension is a fully open-access journal. APC about USD 2,760.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .